Surveillance and Screening of AROs (Antimicrobial Resistant Organisms)

Dr Tom Marrie AROS June 2014

AROs: Key People

Speakers | Jury | Scientific Committee | Organizing Committee 


  • Elizabeth Bryce, BSc, MD, FRCPC
    Regional Medical Director for Infection Control, Vancouver Coastal Health;
    Clinical Professor, University of British Columbia (UBC)
  • Barry Cookson, BDS, MBBS, MSc, HonDipHIC, FRSPH, FRCP, FFPH, FRCPath
    Professor, University College and London School of Hygiene and Tropical Medicine;
    Consultant, World Health Organization (WHO) and European Centre for Disease Control (ECDC)
  • Julian Davies, BSc, PhD, FRS
    Professor Emeritus, Research Team Leader, Department of Microbiology and Immunology, UBC
  • Serge Desnoyers, PhD
    Assistant Director, Canadian Institutes of Health Research-Institute of Infection and Immunity
  • Michael Edmond, MD, MPH, MPA
    Professor, Virginia Commonwealth University; Hospital Epidemiologist, Virginia Commonwealth University Health System
  • Dan Gregson, MD, FRCPC
    Associate Professor, University of Calgary;
    Clinical Section Chief, Medical Microbiology, Calgary Laboratory Services;
    Infectious Diseases Consultant, Calgary, Alberta Health Services
  • Anthony Harris, MD, MPH
    Professor, Epidemiology and Public Health, University of Maryland;
    Acting Medical Director of Infection Control University of Maryland Medical Center
  • Susan Huang, MD, MPH
    Associate Professor, University of California;
    Medical Director of Epidemiology and Infection Prevention at UC Irvine Health
  • John Jernigan, MD, MS
    Director, Office of Prevention Research and Evaluation, Centers for Disease Control and Prevention (CDC);
    Clinical Associate Professor, Emory University School of Medicine, Division of Infectious Diseases
  • Joel Kettner, MD, MSc, FRCSC, FRCPC
    Scientific Lead, National Collaborating Centre for Infectious Diseases, International Centre for Infectious Diseases
  • Mark Loeb, BSc, MSc, MD, FRCPC
    Professor, Department of Pathology and Molecular Medicine;
    Joint Member, Department of Clinical Epidemiology and Biostatistics;
    Medical Director, Infection Control, Hamilton Health Sciences, McMaster University
  • Yves Longtin, MD, FRCPC
    Chair, Infection Prevention and Control Unit, Montreal Jewish General Hospital – SMBD;
    Associate Professor of Medicine, McGill University
  • Scott McEwen, DVM, DVSc, Dip ACVP
    Professor, Ontario Veterinary College, University of Guelph
  • Allison McGeer, MD, FRCPC
    Microbiologist & Infectious Disease Consultant;
    Director of Infection Control;
    Director, Infectious Diseases Epidemiology Research Program, Mount Sinai Hospital and Professor, Laboratory Medicine and Pathobiology and Public Health Sciences, University of Toronto
  • Kim Neudorf, RN, BSN, MEd
    Patients for Patient Safety Champion (PFPS), Canadian Patient Safety Institute
  • Lindsay Nicolle, BSc, BSc (med), MD, FRCPC
    Professor, Department of Internal Medicine and Medical Microbiology, University of Manitoba
  • Howard Njoo, MD, MHSc
    Director General, Centre for Communicable Diseases & Infection Control, Public Health Agency of Canada (PHAC)
  • David Patrick, MD, FRCPC, MHSc
    Professor and Director, School of Population & Public Health, UBC;
    Medical Epidemiology Lead for AMR and the Do Bugs Need Drugs Project, British Columbia Centre for Disease Control (BCCDC)
  • Eli Perencevich, MD, MS
    Professor, Internal Medicine – General Internal Medicine and Epidemiology, University of Iowa Carver College of Medicine
  • Trish Perl, MD, MSc
    Senior Epidemiologist, John Hopkins Health System;
    Professor of Medicine, Johns Hopkins University
  • Pilar Ramon-Pardo, MD, PhD
    Regional Advisor, PAHO/WHO, Washington DC
  • Andrew Simor, MD, FRCPC
    Chief, Department of Microbiology;
    Chief, Division of Infectious Diseases Sunnybrook Health Sciences Centre;
    Senior Scientist, Sunnybrook Research Institute;
    Professor, Departments of Laboratory Medicine & Pathobiology, and Medicine, University of Toronto
  • James Talbot, PhD, MD, FRCPC
    Chief Medical Officer of Health, Alberta Health, Edmonton
  • Henri A. Verbrugh, MD, PhD, FIDSA
    Professor and Chair Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, Rotterdam, The Netherlands
  • Bob Weinstein, MD
    Chairman, Department of Medicine, Cook County Health and Hospitals System;
    Chief Operating Officer, the outpatient Ruth M. Rothstein CORE Center for the Prevention, Care, and Research of Infectious Diseases;
    C. Anderson Hedberg MD Professor of Internal Medicine, Rush University Medical Center, Chicago


Jury Chair

Tom Marrie, MD
Dean, Faculty of Medicine, Dalhousie University


Jury Members

  • Bill Albritton, MD
    Professor and former Dean of Medicine, University of Saskatchewan
  • Helen Branswell
    Medical Reporter, Canadian Press
  • André Corriveau, MD, MBA
    Chief Public Health Officer, NWT and outgoing Chair, Canadian Public Health Network
  • Barb Farlow
    Patients for Patient Safety Canada, Canadian Patient Safety Institute
  • David Heymann, CBE
    Professor of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine;
    Head and Senior Fellow, Chatham House Centre on Global Health Security (London)
  • Steven Lewis, MA
    Health Policy Consultant, Saskatoon, Saskatchewan
  • Pat Piaskowski, RN
    Network Coordinator, Public Health Ontario, Northwestern Ontario Infection Control Network (NWOICN);
    Editor-in-Chief, Canadian Journal of Infection Control
  • Jennifer Rodgers, BSc, MSW, MSc
    Patient Safety Improvement Lead, Canadian Patient Safety Institute
  • John Spika, MD
    Director General, Centre for Immunization and Respiratory Infectious Diseases, Public Health Agency of Canada (PHAC)
  • Howard Waldner, CHE, MBA, ICD.D
    Principal, Caledonia Solutions;
    Former CEO, Vancouver Island Health Authority (also former COO, Calgary Health Region)

Scientific Committee


Dr. John Conly
Professor & Co-Director, Snyder Institute, University of Calgary



Dr. Mark Joffe
Professor, University of Alberta;
Senior Medical Director, Infection Prevention & Control, Alberta Health Services

Dr. Geoffrey Taylor
Professor & Director, Infectious Diseases, University of Alberta

Committee Members

  • Nancy Alfieri
    Executive Director, Infection Prevention & Control, Calgary, South & Central Zones, Alberta Health Services
  • Dr. John Jernigan
    Director, Office of Prevention Research and Evaluation, U.S. Centres for Disease Control & Prevention (NCEZID)
  • Dr. Joel Kettner
    Scientific Lead, National Collaborating Centre for Infectious Diseases, International Centre for Infectious Diseases, Winnipeg
  • Dr. Carmem Lúcia Pessoa-Silva
    Team Lead, Antimicrobial Drug Resistance, World Health Organization
  • Dr. Andrew Simor
    Senior Scientist, Sunnybrook Health Sciences Centre, Toronto

Scientific Sponsor Representatives

  • Public Health Agency of Canada 
    Dr. Howard Njoo, Director General, Centre for Communicable Diseases & Infection Control
  • Canadian Patient Safety Institute 
    Anne MacLaurin, Patient Safety Improvement Lead
  • Accreditation Canada 
    Heather Howley, Health Services Research Specialist
  • Canadian Institutes of Health Research, Institute of Infection & Immunity 
    Dr. Marc Ouellette, Scientific Director

Organizing Committee


Dr. Martin Lavoie
Deputy Chief Medical Officer of Health, Alberta Health

Steve Buick
Director, Policy & Communications, IHE

Committee Members

  • Dr. Mark Joffe
    Professor, University of Alberta;
    Senior Medical Director, Infection Prevention & Control, Alberta Health Services
  • Dawn Friesen
    Executive Director, Health Protection, Alberta Health
  • Melinda Connolly
    Director, Infection Prevention & Control, Alberta Health
  • Samuel Hester
    Project Manager, Infection Prevention & Control, Alberta Health
  • John Sproule
    Senior Director, Health Policy, IHE
  • Dr. Lorne Tyrrell
    Board Chair, IHE;
    CIHR/GSK Chair in Virology, University of Alberta